Moleculin Biotech held its 2023 Annual Meeting of Stockholders, where stockholders voted on various proposals including the election of directors, ratification of an independent registered public accountant, approval of an increase in authorized shares, approval of executive compensation, and amendments to the company's certificate of incorporation. The reverse stock split proposal was adjourned for further solicitation of proxies.